On Friday, Scilex Holding Company (NASDAQ: SCLX) opened higher 3.60% from the last session, before settling in for the closing price of $1.11. Price fluctuations for SCLX have ranged from $0.73 to $3.24 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 14.78%. Company’s average yearly earnings per share was noted 55.08% at the time writing. With a float of $125.34 million, this company’s outstanding shares have now reached $191.79 million.
Considering the fact that the conglomerate employs 105 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 62.2%, operating margin of -195.02%, and the pretax margin is -233.86%.
Scilex Holding Company (SCLX) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Drug Manufacturers – General industry is another important factor to consider. The insider ownership of Scilex Holding Company is 34.65%, while institutional ownership is 20.92%. The most recent insider transaction that took place on May 17 ’24, was worth 43,985. In this transaction Executive Chairperson of this company bought 50,000 shares at a rate of $0.88, taking the stock ownership to the 50,070 shares. Before that another transaction happened on May 17 ’24, when Company’s Director bought 57,500 for $0.90, making the entire transaction worth $51,641. This insider now owns 102,500 shares in total.
Scilex Holding Company (SCLX) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 55.08% per share during the next fiscal year.
Scilex Holding Company (NASDAQ: SCLX) Trading Performance Indicators
Check out the current performance indicators for Scilex Holding Company (SCLX). In the past quarter, the stock posted a quick ratio of 0.19. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.34. Likewise, its price to free cash flow for the trailing twelve months is 18.09.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.02, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.45 in one year’s time.
Technical Analysis of Scilex Holding Company (SCLX)
Compared to the last year’s volume of 1.03 million, its volume of 0.63 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 18.06%. Additionally, its Average True Range was 0.10.
During the past 100 days, Scilex Holding Company’s (SCLX) raw stochastic average was set at 26.68%, which indicates a significant increase from 21.87% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 39.49% in the past 14 days, which was lower than the 119.16% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5546, while its 200-day Moving Average is $1.4312. Nevertheless, the first resistance level for the watch stands at $1.1950 in the near term. At $1.2400, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.2900. If the price goes on to break the first support level at $1.1000, it is likely to go to the next support level at $1.0500. Now, if the price goes above the second support level, the third support stands at $1.0050.
Scilex Holding Company (NASDAQ: SCLX) Key Stats
There are currently 181,190K shares outstanding in the company with a market cap of 220.56 million. Presently, the company’s annual sales total 46,740 K according to its annual income of -114,330 K. Last quarter, the company’s sales amounted to 16,370 K and its income totaled -37,580 K.
